Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Park, Soon-Jung  [Clear All Filters]
2023
Park NKyeong, Park S-J, Park Y-G, Moon S-H, Woo JH, Kim HJong, Kim SJoon, Choi SWoo. Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes. Hum Mol Genet. 2023.
2022
Park S-J, Kim H, Lee S, Kim J, Jung T-H, Choi SWoo, Park B-W, Kang S-W, Elliott DA, Stanley EG, et al. Effect and application of cryopreserved three-dimensional microcardiac spheroids in myocardial infarction therapy. Clin Transl Med. 2022;12(1):e721.
Park J-C, Kim J, Jang H-K, Lee S-Y, Kim K-T, Kwon E-J, Park S, Lee HSik, Choi H, Park S-Y, et al. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors. Biomaterials. 2022;282:121419.
Kim H, Song B-W, Park S-J, Choi SWoo, Moon H, Hwang K-C, Kang S-W, Moon S-H, Yang Y, Kwon IChan, et al. Ultraefficient extracellular vesicle-guided direct reprogramming of fibroblasts into functional cardiomyocytes. Sci Adv. 2022;8(8):eabj6621.
2021
Jung SYong, Kim MSeo, Li H, Lee KHwa, Koyanagi A, Solmi M, Kronbichler A, Dragioti E, Tizaoui K, Cargnin S, et al. Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database. Clin Transl Sci. 2021.
2020
Choi SWoo, Shin JSoo, Park S-J, Jung E, Park Y-G, Lee J, Kim SJoon, Park H-J, Lee J-H, Park S-M, et al. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. Antiviral Res. 2020:104955.
Jung T-H, Bin Chung E-, Kim HWoo, Choi SWoo, Park S-J, Mukhtar ASafaa, Chung H-M, Kim E, Huh KMoo, Kim DSung, et al. Application of co-culture technology of epithelial type cells and mesenchymal type cells using nanopatterned structures. PLoS One. 2020;15(5):e0232899.
Lim S, Yoon HYeol, Park S-J, Song S, Shim MKyu, Yang S, Kang S-W, Lim D-K, Kim B-S, Moon S-H, et al. Predicting in vivo therapeutic efficacy of bioorthogonally labeled endothelial progenitor cells in hind limb ischemia models via non-invasive fluorescence molecular tomography. Biomaterials. 2020;266:120472.
2019
Park S-J, Lee J-H, Lee S-G, Lee JEun, Seo J, Choi JJin, Jung T-H, Bin Chung E-, Kim HNa, Ju J, et al. Functional equivalency in human somatic cell nuclear transfer - derived endothelial cells. Stem Cells. 2019.
Suhito IRosalina, Kang E-S, Kim D-S, Baek S, Park S-J, Moon S-H, Luo Z, Lee D, Min J, Kim T-H. High density gold nanostructure composites for precise electrochemical detection of human embryonic stem cells in cell mixture. Colloids Surf B Biointerfaces. 2019;180:384-392.
Han S-S, Jin Z, Lee B-S, Han J-S, Choi J-J, Park S-J, Chung H-M, Mukhtar ASafaa, Moon S-H, Kang S-W. Reproducible hindlimb ischemia model based on photochemically induced thrombosis to evaluate angiogenic effects. Microvasc Res. 2019:103912.
2013
Moon S-H, Kim S-M, Park S-J, Kim H, Bae D, Choi Y-S, Chung H-M. Development of a Xeno-Free Autologous Culture System for Endothelial Progenitor Cells Derived from Human Umbilical Cord Blood. PLoS One. 2013;8(9):e75224.
Yang H-M, Moon S-H, Choi Y-S, Park S-J, Lee Y-S, Lee H-J, Kim S-J, Chung H-M. Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Endothelial Cells in Humanized Mouse Models Harboring a Human Immune System. Arterioscler Thromb Vasc Biol. 2013.